Home > Analyzers & Analytical Instruments > Pathology Lab Equipments > Chemical Analysis Equipment
Tumor Tissue Analysis
mark as favourite

Tumor Tissue Analysis

Get Latest Price
Cancer is a disease of the genes. Like every human being, each person’s cancer is unique. Unfortunately, conventional ‘Standard of Care’ approach does not take into consideration the overall genetic architecture of a particular patient’s tumor and consequently patients usually suffer due to failed therapies or aggressive relapse. It is thus imperative that the genetic
Contact SellerAsk for best deal
Get Latest PriceRequest a quote
Share via

Datar Genetics Limited

Ambad,, Nashik, Maharashtra
View Mobile Number
Call 09527340889
Verified Supplier
Service Provider
Ask for more details from the seller
Contact Seller

Product Details

Product Description

Cancer is a disease of the genes. Like every human being, each person’s cancer is unique. Unfortunately, conventional ‘Standard of Care’ approach does not take into consideration the overall genetic architecture of a particular patient’s tumor and consequently patients usually suffer due to failed therapies or aggressive relapse. It is thus imperative that the genetic architecture of the tumor is studied comprehensively before deciding the treatment plan.Exacta is useful for cancer patients where
  • First Line Therapy has failed
  • Cancer has relapsed
  • Cancer is High Grade / Metastatic
  • Risk of Therapy Failure is highExacta unravels the deepest genetic secrets of an individual patient’s cancer by accurate, multi-coordinate analysis of all 22,000 genes in the cancer genome. Exacta reaches the depths of cancer’s mechanisms through 100s of millions of data points. This reveals the driver mutations and pathways that are propelling a particular person’s cancer and can be targeted with precision drugs. Exacta thus enables a highly sophisticated treatment strategy beyond conventional perspective. This is the unmatched strength of Exacta. Exacta is the latest and world’s best molecular analysis for difficult cancers. Consider ScreenGeneTM in Patient / Proband with :
    • Cancer at early age e.g. Breast / Ovary / Endometrial / Colorectal at age 50 or younger.
    • Two or more different types of cancer.
    • Cancer in both organs in a set of paired organs e.g. Bilateral Breast cancer.
    • Unusual presentation of cancer e.g. Breast cancer in a Male.
    • Cancer with specific features e.g. Triple negative breast cancer, MSI high colon cancer.
    • Cancer under treatment to identify therapy relevant hereditary gene mutations e.g. BRCA and PARP inhibitors.

Product Image

Tumor Tissue Analysis

Company Details


About us

Legal Status of FirmPrivate Limited Company
Nature of BusinessService Provider
IndiaMART Member SinceNov 2016
Tell Us What Are You Looking For?
I agree to the terms and privacy policy
Tell us what you
need
Receive seller
details
Seal the deal
Save time! Get Best Deal
I agree to the terms and privacy policy



How it Works
Tell us what you need by filling in the form
Receive Verified supplier details
Compare Quotations and seal the deal
X
I agree to the terms and privacy policy
How it Works
Tell us what you need
Receive Verified supplier details
Compare Quotations and seal the deal
X
Tell us your requirement to Get Best Price
Hi
I agree to the terms and privacy policy
Get Best Price
Hi
I agree to the terms and privacy policy